Aytu Biopharma (AYTU) Cash from Operations (2010 - 2026)

Aytu Biopharma (AYTU) reported Cash from Operations of 4182000.0 for Q1 2026, up 35.21% year-over-year from 3092897.57 in Q1 2025, and down 213.8% quarter-over-quarter from 3675000.0 in Q4 2025.

Aytu Biopharma (AYTU) Cash from Operations (2010 - 2026) Analysis & Trends

Aytu Biopharma (AYTU) has 17 years of Cash from Operations data on file, last reported at 4182000.0 in Q1 2026.

  • Cash from Operations for Q1 2026 came in at 4182000.0, up 35.21% year-over-year; the trailing twelve-month figure through Mar 2026 was 1678000.0 (up 130.35% YoY), and the FY2025 annual result was 1937000.0, down 39.55% from the prior year.
  • Cash from Operations retreated to 4182000.0 in Q1 2026 per AYTU's latest filing, from 3675000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 9365000.0 in Q2 2023 and troughed at 9115000.0 in Q1 2022.
  • A 5-year average of 1517000.0 and a median of 788000.0 in 2024 frame the typical range for Cash from Operations.
  • The sharpest annual moves came in 2024 and 2025: Cash from Operations surged 2251.85% in 2024, then tumbled 2441.34% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 2500000.0 in 2022, then surged by 94.6% to 135000.0 in 2023, then surged by 2251.85% to 2905000.0 in 2024, then grew by 26.51% to 3675000.0 in 2025, then plunged by 213.8% to 4182000.0 in 2026.
  • Business Quant data shows AYTU's Cash from Operations at 4182000.0 in Q1 2026, 3675000.0 in Q4 2025, and 618000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -40.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 401.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 463.30 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 145.80 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -165.74 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 89.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 125.13 Mn
10 Aytu Biopharma 24.60 Mn -2.12 Mn 7.60 Mn -4.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.18 Mn
Mar 31, 2026 -4.18 Mn
Dec 31, 2025 3.68 Mn
Dec 31, 2025 3.68 Mn
Sep 30, 2025 -618,000.00
Sep 30, 2025 -618,000.00
Jun 30, 2025 2.80 Mn
Jun 30, 2025 2.80 Mn
Mar 31, 2025 -6.46 Mn
Mar 31, 2025 -6.46 Mn
Dec 31, 2024 2.91 Mn
Dec 31, 2024 2.91 Mn
Sep 30, 2024 -1.19 Mn
Sep 30, 2024 -1.19 Mn
Jun 30, 2024 -788,000.00
Jun 30, 2024 -788,000.00
Mar 31, 2024 -254,000.00
Mar 31, 2024 -254,000.00
Dec 31, 2023 -135,000.00
Dec 31, 2023 -135,000.00